• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Acura Pharmaceuticals Inc

+ Add to Watchlist

HD4:GR

0.726 EUR 0.008 1.11%

As of 09:35:02 ET on 08/29/2014.

Snapshot for Acura Pharmaceuticals Inc (HD4)

Open: 0.677 Day's Range: 0.677 - 0.731 Volume: 0
Previous Close: 0.718 52wk Range: 0.595 - 1.600 1-Yr Rtn: -36.04%

Stock Chart for HD4

No chart data available.
  • HD4:GR 0.726
  • 1D
  • 1M
  • 1Y
0.718
Interactive HD4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HD4

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1550
Est. PEG Ratio -
Market Cap (M EUR) 35.46
Shares Outstanding (M) 48.85
30 Day Average Volume 4
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HD4

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HD4

Acura Pharmaceuticals Inc. is a pharmaceutical technology development company. The Company researches, develops, and manufactures active pharmaceutical ingredients (APIs) used as raw materials in the production of pharmaceutical products. Acura has developed technologies for use in narcotic-based pain management products.

Robert B JonesPresident/CEOPeter A ClemensSenior VP/CFO/Secretary
Robert A SeiserVP/Treasurer/ControllerAlbert W BrzeczkoVP:Technical Affairs
More Company Profile & Key Executives for HD4

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil